How flavor bans affect smoking and vaping
Assessing the Impact of Flavor Restrictions on Smoking and Vaping
This project looks at whether bans on flavored e-cigarettes change how teens and adults use vapes, cigarettes, and cigars.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11168765 on NIH RePORTER |
What this research studies
From a patient perspective, researchers combine national surveys of adolescents and adults with retail sales records and detailed maps of state and local flavor restrictions to see what people actually do after policies change. They use quasi-experimental methods that compare places and times with and without flavor rules to estimate likely effects on vaping and smoking. The team will test whether results differ by age group, urban versus rural location, and by policy details such as retailer exemptions. The goal is to produce nationally relevant findings that can inform safer policy choices.
Who could benefit from this research
Good fit: The research focuses on adolescents and adults who use e-cigarettes, vapes, cigarettes, or cigars, and people living where flavor-sale restrictions were recently implemented.
Not a fit: People who have never used tobacco or e-cigarettes, or those living outside the United States, are unlikely to get direct benefit from this project.
Why it matters
Potential benefit: If successful, the work could help policymakers design flavor rules that reduce youth vaping while avoiding unintended increases in cigarette smoking.
How similar studies have performed: Previous studies have shown mixed results—some report reduced youth vaping after flavor bans while others report rises in cigarette use—so this project uses broader national data and stronger methods to clarify those findings.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Friedman, Abigail S. — University of Michigan at Ann Arbor
- Study coordinator: Friedman, Abigail S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.